|
|
Yew Bio pharm Group Inc (YEWB) |
|
|
|
Yew Bio Pharm Group Inc 's Yearly Income from Continued Operations Growth 5 Years |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual Income from Cont. Operations Annual Growth Rates Y/Y▼
|
Annual Income from Cont. Operations Annual Growth Rates Y/Y▼
|
YEWB Annual Income from Cont. Operations Growth |
2020
|
2019
|
2018
|
2017
|
2016
|
Y / Y Annual Income from Cont. Operations Change |
48.64 % |
- |
- |
60.1 % |
-62.02 % |
Annual Income from Cont. Operations (in millions $) |
$1.46 |
$0.99 |
$-1.32 |
$3.21 |
$2.01 |
Annual Income from Cont. Operations Growth
Comment |
Yew Bio Pharm Group Inc 's Annual Income from Cont. Operations for the fiscal year ended 2020, soared by 48.64% to $1.46 millions, from $0.99 millions achieved a year ago. Yew Bio Pharm Group Inc 's growrh rate for Income from Continued Operations improved from -174.52 % decline in the fiscal year 2019.
Yew Bio Pharm Group Inc Annual Income Statement
|
You need to upgrade your Flash Player
|
Companies with similar 2020 Annual Income from Cont. Operations within Consumer Non Cyclical Sector | Y/Y Income from Continued Operations Growth % | 2020 Annual Income from Cont. Operations | Millerknoll Inc | | | |